Blood Test News and Research

RSS

Biomarker discovery offers hope for lung cancer blood test

Blood levels of a variant form of the nuclear matrix protein Ciz1 are significantly higher in individuals with early- and late-stage lung cancer than in lung cancer-free individuals, researchers report.

31 Oct 2012

Scientists identify mechanism via Top2b enzyme that drives doxorubicin-induced heart damage

Doxorubicin, a 50-year-old chemotherapy drug still in widespread use against a variety of cancers, has long been known to destroy heart tissue, as well as tumors, in some patients.

29 Oct 2012

Canadian Task Force on Preventive Health Care releases new diabetes screening guidelines

Routine screening for type 2 diabetes in adults at low and moderate risk is not recommended, although it is recommended for people at high and very high risk of the disease, state new diabetes screening guidelines published in CMAJ.

17 Oct 2012

GE Healthcare launches new online patient and caregiver resource for Parkinson's disease

As part of GE Healthcare's ongoing commitment to provide resources for those living with movement disorders, the company announced today a new online patient and caregiver resource - www.Move2Answers.com.

15 Oct 2012

Researchers identify new genetic signature for sarcoidosis

Researchers at the University of Illinois Hospital & Health Sciences System have identified a genetic signature that distinguishes patients with complicated sarcoidosis, an inflammatory lung disease that can be fatal, from patients with a more benign form of the disease. The gene signature could become the basis for a simple blood test.

15 Oct 2012

Insight into how coeliac disease is triggered

For the first time, scientists have visualised an interaction between gluten and T-cells of the immune system, providing insight into how coeliac disease, which affects approximately 1 in 133 people, is triggered.

12 Oct 2012

Amarantus acquires option to license LymPro Alzheimer's diagnostic blood test from MDx

Amarantus BioSciences, Inc., a biotechnology company developing new treatments and diagnostics for Parkinson's disease and Traumatic Brain Injury centred on its proprietary anti-apoptotis therapeutic protein MANF, today announced that it has acquired an exclusive option to license the LymPro Alzheimer's Diagnostic Blood Test from Memory Dx, LLC (MDx), formerly known as Provista Life Sciences, LLC.

11 Oct 2012

Inpeco, Precise Biometrics partner to deploy Precise Match-on-Card technology

Precise Biometrics announces today that they have partnered with the Inpeco Group for a 6-month contract, to deploy Precise Match-on-Card technology to the Inpeco Group System.

11 Oct 2012

Clear link between neurotensin and CVD, type 2 diabetes and breast cancer

"It was surprising to find such a clear link to the risk of type 2 diabetes and cardiovascular disease as well as to breast cancer. Obesity is a common risk factor for all three conditions, but the connection with neurotensin is not explained by obesity or other known risk factors", says Professor Olle Melander from the Department of Clinical Sciences at Lund University, who is also a consultant at Sk-ne University Hospital.

11 Oct 2012

Fibulin-3 protein may help identify mesothelioma in early stages

Researchers at NYU School of Medicine have discovered the protein product of a little-known gene may one day prove useful in identifying and monitoring the development of mesothelioma in early stages, when aggressive treatment can have an impact on the progression of disease and patient prognosis.

11 Oct 2012

Six-gene signature can predict survival in men with aggressive prostate cancer

Researchers from Mount Sinai School of Medicine have identified a six-gene signature that can be used in a test to predict survival in men with aggressive prostate cancer, according to new research published in the October issue of The Lancet Oncology.

11 Oct 2012

Spanish and British scientists design new blood test to identify aggressive prostate cancer

Scientists from the Spanish National Cancer Research Centre (CNIO) in Madrid, along with British colleagues from the Institute for Cancer Research (ICR) and the Royal Marsden NHS Foundation Trust, have developed a test that studies genetic patterns in blood cells to detect advanced-stage prostate cancer.

10 Oct 2012

New blood test can read genetic changes in prostate cancer

Scientists have designed a blood test that reads genetic changes like a barcode - and can pick out aggressive prostate cancers by their particular pattern of gene activity.

9 Oct 2012

Tips to differentiate between children's cold and allergies

One of the problems that parents may have during the fall is deciphering whether their children's sneezing is due to a cold or allergies.

6 Oct 2012

GW professor to develop blood test for early detection of breast cancer

Today, patients with precancerous lesions, or early-stage breast cancer are usually diagnosed after a mammography screening. This method of detection can lead to false-positives and overtreatment, since mammography cannot determine whether pre-cancerous cells will actually turn into breast cancer. This may all change after Sidney Fu, M.D., professor of medicine at the George Washington School of Medicine and Health Sciences (SMHS), completes his study of early breast cancer detection using novel small RNA (microRNA or miRNA) biomarkers.

5 Oct 2012

New colonoscopy surveillance guidelines from U.S. Multisociety Task Force

Patients at average risk of colorectal cancer who have a clean colonoscopy do not need to repeat the test for 10 years. This and many other practical recommendations for cancer prevention were issued in "Guidelines for Colonoscopy Surveillance After Screening and Polypectomy," a consensus update issued by the U.S. Multisociety Task Force on Colorectal Cancer.

3 Oct 2012

New clinical study to determine whether DNA in blood could show early signs of breast cancer

A SIMPLE blood test could one day be a more accurate way to test for the early signs of breast cancer than using mammograms to spot a lump say researchers today, as Breast Cancer Awareness Month gets underway.

3 Oct 2012

UCSD receives NCI grant to continue research into chronic lymphocytic leukemia

An international consortium of scientists studying chronic lymphocytic leukemia (CLL), based at the University of California, San Diego School of Medicine, has been awarded a 5-year, $20 million grant by the National Cancer Institute, part of the National Institutes of Health.

28 Sep 2012

KSU creates simple blood test that can accurately detect lung and breast cancer’s early stages

Researchers at Kansas State University have developed a simple blood test that can accurately detect the beginning stages of cancer.

27 Sep 2012

Blood test for monitoring Huntington’s disease may be possible in future

Measuring blood levels of mutant huntingtin protein may provide an alternative approach of determining the onset of Huntington’s disease in known carriers, researchers report.

26 Sep 2012